Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-030725
Filing Date
2018-06-29
Accepted
2018-06-29 16:33:08
Documents
1
Period of Report
2018-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3355
  Complete submission text file 0001140361-18-030725.txt   4836
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address REXAHN PHARMACEUTICALS, INC. 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Cheong Kwang Soo (Reporting) CIK: 0001361686 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 18929687